- Home
- VACH vs IMMP Comparison
VACH vs IMMP Comparison
Compare VACH & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VACH
- IMMP
- Stock Information
- Founded
- VACH 2023
- IMMP 1987
- Country
- VACH United States
- IMMP Australia
- Employees
- VACH N/A
- IMMP N/A
- Industry
- VACH
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- VACH
- IMMP Health Care
- Exchange
- VACH NYSE
- IMMP Nasdaq
- Market Cap
- VACH 324.2M
- IMMP 211.1M
- IPO Year
- VACH 2024
- IMMP N/A
- Fundamental
- Price
- VACH $10.29
- IMMP $1.86
- Analyst Decision
- VACH
- IMMP Buy
- Analyst Count
- VACH 0
- IMMP 2
- Target Price
- VACH N/A
- IMMP $8.50
- AVG Volume (30 Days)
- VACH 177.1K
- IMMP 648.0K
- Earning Date
- VACH 01-01-0001
- IMMP 05-16-2025
- Dividend Yield
- VACH N/A
- IMMP N/A
- EPS Growth
- VACH N/A
- IMMP N/A
- EPS
- VACH 0.26
- IMMP N/A
- Revenue
- VACH N/A
- IMMP $3,019,249.00
- Revenue This Year
- VACH N/A
- IMMP $11.25
- Revenue Next Year
- VACH N/A
- IMMP $10.22
- P/E Ratio
- VACH $40.05
- IMMP N/A
- Revenue Growth
- VACH N/A
- IMMP 24.11
- 52 Week Low
- VACH $9.95
- IMMP $1.32
- 52 Week High
- VACH $11.20
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- VACH N/A
- IMMP 53.43
- Support Level
- VACH N/A
- IMMP $1.44
- Resistance Level
- VACH N/A
- IMMP $2.71
- Average True Range (ATR)
- VACH 0.00
- IMMP 0.17
- MACD
- VACH 0.00
- IMMP 0.05
- Stochastic Oscillator
- VACH 0.00
- IMMP 29.75
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.